“We need to collaborate”: CX Aortic Live panel probes future of Endo-Bentall

2025-03-28T19:29:50+00:00

 

The minimally invasive Endo-Bentall procedure for the treatment of aortic root pathologies was the focus of a recent roundtable discussion at CX Aortic Live 2024 (7–8 October, Vienna, Austria). After agreeing on a precise definition for this “last frontier” in cardiovascular interventions—as described by discussion chair and course co-director Tilo Kölbel (University of Hamburg, Hamburg, […]

“We need to collaborate”: CX Aortic Live panel probes future of Endo-Bentall2025-03-28T19:29:50+00:00

CX Aortic Live Studio: Professor Dittmar Böckler

2024-10-15T15:20:19+01:00

One of the highlights of the day two programme was a live case from CX Symposium co-chair Dittmar Böckler (Heidelberg, Germany) and team, who presented a live open repair of an abdominal aortic aneurysm (AAA) in a young patient with Marfan syndrome. “Treatment of […]

CX Aortic Live Studio: Professor Dittmar Böckler2024-10-15T15:20:19+01:00

Meet the CX Aortic Live Executive Board: Professor Luca Bertoglio

2024-09-11T10:03:59+01:00

“The important thing [about taking a multidisciplinary approach] is that our skills build up in time differently around the aorta.”

The CX Aortic Live team sat down with Associate Professor of Vascular Surgery at the University of Brescia, Luca Bertoglio to take a behind the scenes look […]

Meet the CX Aortic Live Executive Board: Professor Luca Bertoglio2024-09-11T10:03:59+01:00

Hear the latest thoughts on paclitaxel from global experts: their current practice and patient conversations

2019-09-06T16:19:25+01:00

Following the latest information presented at the Charing Cross International Symposium related to the meta-analysis of paclitaxel-coated devices (Katsanos et al, JAHA), hear from a multi-specialty panel of global experts who are discussing their current practice and the way they […]

Hear the latest thoughts on paclitaxel from global experts: their current practice and patient conversations2019-09-06T16:19:25+01:00

CX Special Session will discuss the use of paclitaxel devices

2019-09-06T16:37:19+01:00

CX Executive Board Members Gunnar Tepe and Thomas Zeller introduce the CX Special Session which aims to give the last word on paclitaxel and work with the vascular community to find the way forward.

Watch the video below, and see the final CX 2019 programme here.

[…]

CX Special Session will discuss the use of paclitaxel devices2019-09-06T16:37:19+01:00

CX 2019: Vascular EDUCATION as it should be

2020-02-14T14:51:28+00:00

CX is Europe’s largest and longest-running vascular symposium and delivers vascular EDUCATION as it should be

CX raises CONTROVERSIESCHALLENGES the evidence to reach CONSENSUS in a three yearly cycle after discussion involving a world-class faculty and expert audience.

CX uses both live cases and edited cases from leading aortic, peripheral and venous centres to illustrate […]

CX 2019: Vascular EDUCATION as it should be2020-02-14T14:51:28+00:00

CX 2019 Vascular Access Programme Highlights

2019-09-06T16:38:16+01:00

Nicholas Inston, member of the CX Vascular Access Executive Board, gives the highlights for this year’s CX Vascular Access Masterclass which will focus on the maintenance and not just the formation of vascular access.

CX 2019 Vascular Access Programme Highlights2019-09-06T16:38:16+01:00

CX 2019: Stephen Black on the Venous Challenges programme

2019-09-06T16:41:17+01:00

Stephen Black, member of the CX Venous Executive Board, describes the wonderful opportunity that the Charing Cross Venous Challenges Programme offers as it brings together key developments in the science, learning experience in the Venous Village and input from the international faculty who share their vision.

CX 2019: Stephen Black on the Venous Challenges programme2019-09-06T16:41:17+01:00

CX 2017 “Drive to get Consensus”: Andrew Holden on what makes CX so special

2017-02-04T03:56:25+00:00

What are the special features of the CX Symposium? CX Programme Organising Board member Andrew Holden (Associate Professor of Radiology at Auckland University School of Medicine and Director of Interventional Services at Auckland City Hospital, Auckland, New Zealand) highlights the discussion, debate and “a drive to get consensus”.

CX 2017 “Drive to get Consensus”: Andrew Holden on what makes CX so special2017-02-04T03:56:25+00:00
Go to Top